Esterified Cholesterol Conjugates Enable LNP-Mediated mRNA Delivery to the Blood-Brain Barrier Following Intravenous Administration.
This study presents a ligand-free lipid nanoparticle (LNP) platform that enables efficient mRNA delivery to the brain endothelium via systemic administration and establishes a new class of cholesterol-based lipids that provides a foundation for next-generation RNA therapeutics targeting BBB-associated diseases.